More shoulder instability episodes may increase recurrence rate

NEW ORLEANS — Patients with two or more shoulder instability episodes before arthroscopic Bankart repair had a significant increase in risk for recurrent instability postoperatively, according to results presented here.
“When a patient has one preoperative instability episode, considering surgery would help them have a better outcome,” Ryan T. Lin, BS, first author of the study and third year medical student at the University of Pittsburgh School of Medicine, told Healio about results presented at the American Academy of Orthopaedic Surgeons Annual Meeting Specialty Day. “Once

Cardiology is ‘shifting in a good way’: Here’s what PCPs should know

SAN FRANCISCO — Cardiovascular care is transitioning from primarily managing acute conditions to focusing on prevention and interventions for earlier-stage disease, according to Alison L. Bailey, MD, FACC, FASPC.
“Cardiology is shifting, and I think it’s shifting in a good way,” Bailey, vice chair of cardiology and chief of noninvasive services at West Virginia University’s Heart and Vascular Institute, said during her talk at the ACP Internal Medicine Meeting.
A recent example of this transformation is the newly released 2026 American College of

Toothbrushing lowers hospital-acquired pneumonia risk

MUNICH — Brushing your teeth can prevent cavities — and pneumonia — a team of Australian researchers found.
According to a study of nearly 9,000 participants, cases of non-ventilator hospital-acquired pneumonia (NV-HAP) among patients equipped with a toothbrush, toothpaste and educational materials on oral hygiene dropped from 0.87 to 0.39 — or 55% — for every 100 admission days patients were at risk.
“This study shows the importance of oral care which is often deprioritized,” researcher Brett Mitchell, PhD, professor of health services research and nursing at Avondale University in Cooranbong,

Intervention improves breast cancer screening for homeless people

An intervention designed to expand routine cancer screening observed increases in mammogram uptake but not cervical and colorectal screenings among individuals experiencing homelessness.
The data, presented at American Association for Cancer Research Annual Meeting, showed that after implementation of a screening strategy that included text messaging and patient navigation at a large federally qualified health center, breast cancer screening rates increased more than 4 percentage points among women experiencing homelessness.
However, declines in cervical and colorectal cancer screening

FDA approves Tzield to delay type 1 diabetes for young children

The FDA has approved an expanded indication for the CD3-directed monoclonal antibody teplizumab-mzwv to delay stage 3 type 1 diabetes onset for children as young as age 1 year, according to an industry press release.
As Healio previously reported, teplizumab-mzwv (Tzield, Sanofi) was approved by the FDA in 2022 to delay onset of stage 3 type 1 diabetes among children and adults aged 8 years or older with stage 2 type 1 diabetes. Stage 2 type 1 diabetes is defined as the presence of at least two type 1 diabetes-related autoantibodies and abnormal glucose levels. Stage 3 type 1 diabetes is

KDIGO report highlights green dialysis strategies, innovations

Creating more environmentally sustainable dialysis practices requires collaborative efforts and innovations to the field, according to a Kidney Disease: Improving Global Outcomes report.
Hemodialysis, hemodiafiltration and peritoneal dialysis use large amounts of water, energy, disposable materials and transportation resources, making these treatments some of the most resource-intensive medical therapies, according to Jennifer E. Flythe, MD, MPH, chief of the division of nephrology and hypertension at University of North Carolina School of Medicine, and colleagues.
Because of the heavy resource

‘Never assume’: Teaching clinical reasoning at ACP

SAN FRANCISCO — Skepticism and clinical reasoning can be powerful teaching tools for the next generation of primary care physicians, according to a speaker here.
Robert M. Centor, MD, MACP, chair emeritus of the ACP Board of Regents and professor emeritus at The University of Alabama at Birmingham, offered a presentation on clinical reasoning at the annual ACP Internal Medicine meeting.
Healio spoke with Centor to learn more about the presentation, tips to help teach clinical reasoning, the value of skepticism and more.
Healio: Why did you decide to present on this topic? Why is it important for

ACOG updates guidance for evaluating postmenopausal bleeding

ACOG issued updated guidance recommending endometrial tissue sampling as well as transvaginal ultrasonography when initially evaluating postmenopausal bleeding.
“Because the incidence of endometrial cancer in the United States has been rising steadily for decades, this guidance is designed to support clinicians to perform earlier and more comprehensive screenings,” ACOG President Steven J. Fleischman, MD, MBA, FACOG, said in a press release. “It gives clinicians a more robust framework for evaluating patients with postmenopausal bleeding — one that prioritizes prompt diagnosis and reduces the

Improved biological age linked to lower stroke risk

CHICAGO — Improving the gap between biological and chronological ages was associated with a decreased risk for stroke and improved brain health, according to a poster presented at the American Academy of Neurology Annual Meeting.
“It’s exciting to think that working to modify our biological age could be a pathway to preserving brain health,” Cyprien Rivier, MD, MSc, instructor, department of neurology, Yale School of Medicine, said in a press release.
“Lifestyle habits that support cardiovascular and metabolic health, like a healthy diet, regular exercise, adequate sleep and good blood pressure

Male pattern hair loss drug regrows hair up to 1 year without plateau

Men with androgenetic alopecia who used clascoterone 5% topical solution for 12 months saw continued improvement in hair growth while those who stopped active treatment at 6 months began losing hair again, according to topline data.
For the phase 3 SCALP 1 and SCALP 2 studies, responders to 6 months of clascoterone 5% topical solution (Cosmo Pharmaceuticals) were rerandomized to continue clascoterone or switch to vehicle for another 6 months. The studies included 1,465 men with mild to moderate androgenic alopecia from 51 centers in the United States and Europe. The pivotal studies evaluated